Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Change in Taxes: 2023-2025

Historic Change in Taxes for Gyre Therapeutics (GYRE) over the last 3 years, with Sep 2025 value amounting to $1.5 million.

  • Gyre Therapeutics' Change in Taxes rose 187.10% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$152,000, marking a year-over-year increase of 93.71%. This contributed to the annual value of -$2.2 million for FY2024, which is 172.13% down from last year.
  • Latest data reveals that Gyre Therapeutics reported Change in Taxes of $1.5 million as of Q3 2025, which was up 199.42% from $513,000 recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Change in Taxes ranged from a high of $2.5 million in Q3 2023 and a low of -$4.2 million during Q2 2024.
  • In the last 3 years, Gyre Therapeutics' Change in Taxes had a median value of $513,000 in 2025 and averaged $56,364.
  • Examining YoY changes over the last 5 years, Gyre Therapeutics' Change in Taxes showed a top increase of 187.10% in 2025 and a maximum decrease of 259.24% in 2025.
  • Gyre Therapeutics' Change in Taxes (Quarterly) stood at -$185,000 in 2023, then spiked by 135.14% to $65,000 in 2024, then surged by 187.10% to $1.5 million in 2025.
  • Its Change in Taxes stands at $1.5 million for Q3 2025, versus $513,000 for Q2 2025 and -$2.3 million for Q1 2025.